ArticlesSeries A
Matchpoint Therapeutics Raises $150M From Nextech Invest
Matchpoint Therapeutics raises $150M Series A+ led by Nextech Invest.
By Traded Media1 min read
Matchpoint Therapeutics raises $150M Series A+ led by Nextech Invest.
Matchpoint Therapeutics develops advancing the discovery of precision covalent medicines. The company is led by CEO Andre Turenne Credit.
| Company | Matchpoint Therapeutics |
|---|---|
| Round | Series A+ |
| Amount | $150M |
| Lead Investor | Nextech Invest |
| Founders | Andre Turenne Credit |
| Sectors | biotechnology |
ABOUT THIS STORY
- Desk
- Articles
- Filed
- Oct 9, 2026
- By
- Traded Media
